Nateglinide (AvKARE, Inc.)
Welcome to the PulseAid listing for the Nateglinide drug offered from AvKARE, Inc.. This Glinide [EPC],Potassium Channel Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | AvKARE, Inc. |
NON-PROPRIETARY NAME: | Nateglinide |
SUBSTANCE NAME: | NATEGLINIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Glinide [EPC],Potassium Channel Antagonists [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-04-06 |
END MARKETING DATE: | 0000-00-00 |
Nateglinide HUMAN PRESCRIPTION DRUG Details:
Item Description | Nateglinide from AvKARE, Inc. |
LABELER NAME: | AvKARE, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 60(mg/1) |
START MARKETING DATE: | 2016-04-06 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 42291-636_ade26270-43a3-d0bb-0597-55d0e095c74c |
PRODUCT NDC: | 42291-636 |
APPLICATION NUMBER: | ANDA077463 |
Other NATEGLINIDE Pharmaceutical Manufacturers / Labelers: